The Global Insect Pest Control Market has witnessed continuous growth in the last few years and is projected to grow even further during the forecast period of 2024-2033. The assessment provides a 360° view and insights - outlining the key outcomes of the Insect Pest Control market, current scenario analysis that highlights slowdown aims to provide unique strategies and solutions following and benchmarking key players strategies. In addition, the study helps with competition insights of emerging players in understanding the companies more precisely to make better informed decisions.

Browse for Full Report at @ https://www.thebrainyinsights.com/report/insect-pest-control-market-12654

Recent Development

• Demand tailwinds from vector-borne disease surges. Dengue reached record levels across 2024–2025 (e.g., >13–14M cases in 2024; 3.6M+ reported already in 2025), lifting public-health mosquito control budgets and service demand.

• Service leaders post solid growth.

• • Rentokil Initial: FY-2024 revenue up; Pest Control revenue ~£4.41B (+2.9% YoY). Q4-2024 North America organic growth re-accelerated to 2.3%. 

  • Rollins (Orkin): FY-2024 revenue ~$3.4B (+10.3% YoY). 

• Agrochemical suppliers navigating downcycle but remain large.

  • Syngenta Crop Protection FY-2024 sales $13.2B (-13% YoY) amid channel destocking. 

  • FMC FY-2024 revenue $4.25B; pivoting toward biologicals/pheromones; highlighted pipeline on recent calls. 

Drivers

• Urbanization & hygiene compliance boosting residential/commercial services demand. (Industry overviews)

• Climate change & globalization expanding insect ranges (Aedes spp.), increasing outbreaks and control spending.

• Food safety & audit standards sustaining demand for IPM in food processing, logistics, and retail. (Industry overviews) 

Restraints

• Tightening regulation on insecticides (e.g., EU outdoor bans on key neonics since 2018; U.S. EPA endangered-species mitigations).

• Resistance management and phase-outs raising costs and shifting portfolios toward alternatives. (Regulatory context & industry commentary)

Regional segmentation analysis

• North America: Largest commercial services market; dense service networks (Rentokil, Rollins) and strong food/health regulation sustain growth. 

• Europe: Demand solid but product regulation is strict (neonics bans), nudging adoption of non-chemical IPM and digital monitoring. 

• Latin America: High vector-control demand amid record dengue seasons; municipal contracts and household spend rising. 

• Asia-Pacific: Fastest growth on urban expansion and rising middle-class hygiene standards. (Industry overviews) 

Emerging Trends

• Digital/IoT monitoring (e.g., Rentokil PestConnect; Anticimex SMART) enabling remote, data-driven control. 

• Biologicals & biorationals (e.g., Bti larvicides like VectoBac from Valent BioSciences/Sumitomo) and pheromones for resistance-friendly IPM. 

• Service consolidation and cross-sell hygiene/air-care with pest portfolios (global roll-ups by Rentokil, Rollins).

Top Use Cases

• Residential & commercial (restaurants, retail, offices, hospitality). (Market overviews)

• Food & beverage processing / logistics (stored-product pests; audit readiness).

• Public-health vector control (mosquito abatement, larviciding). 

• Agriculture & livestock (on-farm insect control; crop protection programs).

Major Challenges

• Regulatory uncertainty and active-ingredient withdrawals complicate product lifecycles. 

• Insecticide resistance pushing rotations/alternatives and increasing program complexity. (Regulatory & market context) 

• Labor availability for service routes; training for IPM and digital tools (industry commentary). 

Attractive Opportunities

• APAC & LATAM expansion (urban growth + vector control demand). 

• Biologicals/low-tox solutions (Bti, IGRs, pheromones) aligned with regulation & ESG. 

• Smart monitoring & data services (contract stickiness, premium pricing).

Key factors of market expansion

1. Urban density & rising hygiene expectations in emerging metros.

2. Vector-borne disease volatility driving municipal and household spend.

3. Tech-enabled IPM improving efficacy and compliance (IoT traps/analytics). 

4. Shift to greener chemistries/biologicals opening new SKUs and contracts.

5. Industry consolidation creating national/global route density and cross-sell. 

Company references with values (illustrative leaders)

• Rentokil Initial (Global #1 services)
  FY-2024 Pest Control revenue ~£4.41B (+2.9% YoY). Q4-2024 North America organic +2.3%. Digital PestConnect scaling across markets. 

• Rollins / Orkin (Global #2 services)
  FY-2024 revenue ~$3.4B (+10.3% YoY); 2.8M customers served per 2024 AR highlights.

• Syngenta Group – Crop Protection (key supplier of insecticides/biologicals)
  FY-2024 Crop Protection sales $13.2B (-13% YoY) amid destocking; expecting stabilization in 2025.

•  

• FMC Corporation (diamides, biologicals, pheromones pipeline)
  FY-2024 revenue $4.25B; ongoing shift toward higher-growth bio/pheromone lines discussed in 2025 calls.

• Regulatory context affecting all suppliers
  EU bans on outdoor use of imidacloprid, clothianidin, thiamethoxam since Dec 2018; U.S. EPA advancing endangered-species mitigations for neonics.

Note on market size

Public, recent estimates for pest control (all pests) show a mid-single-digit to high-single-digit CAGR to ~2031. Many reports aggregate “pest control” (rodents, termites, insects). Where broken out, “insect pest control” is typically the largest slice. Use directionally: growing from mid-$20Bs in the early-2020s to low-$40Bs by 2031.

If you want, I can tailor this to a slide-friendly one-pager for stakeholders (and add more company comps like BASF, Bayer, ADAMA, Corteva, Anticimex) with specific product/category callouts.